Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Twelve-month tolerability and safety of sumatriptan-naproxen sodium for the treatment of acute migraine.

Winner P, Cady RK, Ruoff GE, Frishberg BM, Alexander WJ, Zhang Y, Kori SH, Lener SE.

Mayo Clin Proc. 2007 Jan;82(1):61-8.

PMID:
17285787
2.

Sumatriptan plus naproxen for the treatment of acute migraine attacks in adults.

Law S, Derry S, Moore RA.

Cochrane Database Syst Rev. 2016 Apr 20;4:CD008541. doi: 10.1002/14651858.CD008541.pub3. Review.

PMID:
27096438
3.

Sumatriptan plus naproxen for acute migraine attacks in adults.

Law S, Derry S, Moore RA.

Cochrane Database Syst Rev. 2013 Oct 21;(10):CD008541. doi: 10.1002/14651858.CD008541.pub2. Review. Update in: Cochrane Database Syst Rev. 2016;4:CD008541.

PMID:
24142431
4.

Sumatriptan/naproxen sodium: a review of its use in adult patients with migraine.

Yang LP.

Drugs. 2013 Aug;73(12):1339-55. doi: 10.1007/s40265-013-0099-y. Review.

PMID:
23912627
5.

Pharmacological synergy: the next frontier on therapeutic advancement for migraine.

Blumenfeld A, Gennings C, Cady R.

Headache. 2012 Apr;52(4):636-47. doi: 10.1111/j.1526-4610.2011.02058.x. Epub 2012 Jan 6. Review.

PMID:
22221151
6.

Sumatriptan/Naproxen Sodium: A Review in Migraine.

Syed YY.

Drugs. 2016 Jan;76(1):111-21. doi: 10.1007/s40265-015-0521-8. Review.

PMID:
26628293
7.

Sumatriptan-naproxen fixed combination for acute treatment of migraine: a critical appraisal.

Khoury CK, Couch JR.

Drug Des Devel Ther. 2010 Feb 18;4:9-17. Review.

8.

Meta-analysis of the efficacy and safety of naproxen sodium in the acute treatment of migraine.

Suthisisang CC, Poolsup N, Suksomboon N, Lertpipopmetha V, Tepwitukgid B.

Headache. 2010 May;50(5):808-18. doi: 10.1111/j.1526-4610.2010.01635.x. Epub 2010 Mar 5. Review.

PMID:
20236345
9.

Clinical applications of new therapeutic deliveries in migraine.

Dahlöf C.

Neurology. 2003 Oct 28;61(8 Suppl 4):S31-4. Review.

PMID:
14581656
10.

Sumatriptan/naproxen sodium combination for the treatment of migraine.

Cleves C, Tepper SJ.

Expert Rev Neurother. 2008 Sep;8(9):1289-97. doi: 10.1586/14737175.8.9.1289. Review.

PMID:
18759540
11.

Comparative tolerability of treatments for acute migraine: A network meta-analysis.

Thorlund K, Toor K, Wu P, Chan K, Druyts E, Ramos E, Bhambri R, Donnet A, Stark R, Goadsby PJ.

Cephalalgia. 2017 Sep;37(10):965-978. doi: 10.1177/0333102416660552. Epub 2016 Aug 12. Review.

PMID:
27521843
12.

Sumatriptan iontophoretic transdermal system: a review of its use in patients with acute migraine.

Garnock-Jones KP.

Drugs. 2013 Sep;73(13):1483-90. doi: 10.1007/s40265-013-0104-5. Review.

PMID:
23912626
13.

The clinical profile of sumatriptan: safety and tolerability.

Lloyd K.

Eur Neurol. 1994;34 Suppl 2:40-3. Review.

PMID:
7835382
14.

Tolerability of sumatriptan: clinical trials and post-marketing experience.

Welch KM, Mathew NT, Stone P, Rosamond W, Saiers J, Gutterman D.

Cephalalgia. 2000 Oct;20(8):687-95. Review. Erratum in: Cephalalgia 2001 Mar;21(2):164-5.

PMID:
11167896
15.

Pharmacokinetics and safety of a new aspirin formulation for the acute treatment of primary headaches.

Lecchi M, D'Alonzo L, Negro A, Martelletti P.

Expert Opin Drug Metab Toxicol. 2014 Oct;10(10):1381-95. doi: 10.1517/17425255.2014.952631. Review.

PMID:
25219631
16.

A review of current treatments for migraine.

Diener HC.

Eur Neurol. 1994;34 Suppl 2:18-25. Review.

PMID:
7835378
17.

Migraine treatment: the British perspective.

Wilkinson M.

Headache. 1994 Sep;34(8):S13-6. Review.

PMID:
7960723
18.
19.

Triptans in childhood and adolescence.

Winner P.

Semin Pediatr Neurol. 2001 Mar;8(1):22-6. Review.

PMID:
11332862
20.

Complicated migraine and migraine variants.

Rothner AD.

Semin Pediatr Neurol. 2001 Mar;8(1):7-12. Review.

PMID:
11332867

Supplemental Content

Support Center